These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8875450)

  • 1. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
    Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K
    Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nilvadipine on neuronal function in the ischemic cat brain.
    Takakura S; Furuichi Y; Satoh H; Mori J; Kohsaka M
    Surg Neurol; 1992 Apr; 37(4):255-60. PubMed ID: 1595035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nilvadipine, a dihydropyridine type calcium channel blocker, on local cerebral blood flow in rats.
    Furuichi Y; Takakura S; Satoh H; Mori J; Kohsaka M
    Jpn J Pharmacol; 1992 Apr; 58(4):457-60. PubMed ID: 1405041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
    Paris D; Quadros A; Humphrey J; Patel N; Crescentini R; Crawford F; Mullan M
    Brain Res; 2004 Feb; 999(1):53-61. PubMed ID: 14746921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a Ca2+ entry blocker (nilvadipine) on acute focal cerebral ischemia in rats.
    Kawamura S; Yasui N; Shirasawa M; Fukasawa H
    Exp Brain Res; 1991; 83(2):434-8. PubMed ID: 2022249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats.
    Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M
    Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats.
    Takakura S; Susumu T; Satoh H; Mori J; Shiino A; Handa J
    Jpn J Pharmacol; 1991 Aug; 56(4):547-50. PubMed ID: 1744995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of nilvadipine on rat focal cerebral ischemia.
    Li Y; Kawamura S; Yasui N; Shirasawa M; Fukasawa H
    Exp Brain Res; 1994; 99(1):1-6. PubMed ID: 7925784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride.
    Takakura S; Sogabe K; Satoh H; Mori J; Fujiwara T; Totsuka Z; Tokuma Y; Kohsaka M
    Neurosci Lett; 1992 Jul; 141(2):199-202. PubMed ID: 1436634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nilvadipine on cerebral circulation and metabolism in cats.
    Isozumi K; Izumi Y; Fukuuchi Y; Gotoh F
    Arzneimittelforschung; 1990 Apr; 40(4):421-4. PubMed ID: 2113386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease.
    de Jong DLK; de Heus RAA; Rijpma A; Donders R; Olde Rikkert MGM; Günther M; Lawlor BA; van Osch MJP; Claassen JAHR
    Hypertension; 2019 Aug; 74(2):413-420. PubMed ID: 31203725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of the Ca2+ entry blocker nilvadipine on brain surface microvessels in rats.
    Kawamura S; Yasui N
    Neurol Med Chir (Tokyo); 1994 Oct; 34(10):663-7. PubMed ID: 7529366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single oral administration of nilvadipine on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Okada K; Suyama N; Bokura K; Murao M; Tsunematsu T
    Angiology; 1992 Oct; 43(10):801-9. PubMed ID: 1476267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.